Adamis Pharmaceuticals misses by $0.02, misses on revenue

|About: Adamis Pharmaceuticals ... (ADMP)|By:, SA News Editor

Adamis Pharmaceuticals (NASDAQ:ADMP): Q1 GAAP EPS of -$0.19 misses by $0.02.

Revenue of $4.9M (+53.1% Y/Y) misses by $0.89M.

Shares -1.8%.

Press Release

Subscribe for full text news in your inbox